GLP-1 Receptor Agonists: Cardiometabolic Disease Pathways
Comments Off on GLP-1 Receptor Agonists: Cardiometabolic Disease Pathways
April 24, 2026
Cardiometabolic disease pathways involve complex inflammatory and metabolic mechanisms that contribute to insulin resistance. GLP-1 receptor agonists address these pathways by improving insulin sensitivity and reducing inflammation. Understanding these…
GLP-1 Receptor Agonist Response: How Genes Shape Outcomes
Comments Off on GLP-1 Receptor Agonist Response: How Genes Shape Outcomes
April 12, 2026
Pharmacogenomics drug response variability plays a key role in how patients respond to GLP-1 receptor agonists. Genetic differences can affect both weight loss outcomes and side effect profiles. Understanding these variations supports personalized…
Study Sheds Light on Genetic Addiction Risk for Cannabis, Alcohol, Tobacco, and Opioid Use
Comments Off on Study Sheds Light on Genetic Addiction Risk for Cannabis, Alcohol, Tobacco, and Opioid Use
April 7, 2026
This study highlights genetic addiction risk cannabis and its impact on substance use disorders. Understanding genetic predisposition aids clinicians in risk assessment and treatment planning. Genetic addiction risk cannabis is a key factor in…